Goldman Sachs downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Buy to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

Cowen Raises Price Target on Momenta Phama (MNTA) Following 2Q Results August 5, 2015 9:57 AM Momenta Pharmaceuticals (MNTA) PT Raised to $26 at Leerink PartnersAugust 5, 2015 7:58 AM Momenta Phama (MNTA) Reports Q2 Loss Per Share of 4c August 4, 2015 8:17 AM Momenta Pharmaceuticals Reports Second Quarter 2015 Financial ResultsAugust 4, 2015 8:00 AM